Antacid Bezoar in a Newborn
1 Department of Newborn Medicine, Montreal, Quebec
2 Department of Pharmacology and Therapeutics McGill University-Montreal Children's Hospital Research Institute, Montreal, Quebec
Antacid therapy is commonly used in the medical management of peptic ulcers and massive gastric bleeding. A similar approach has been employed in newborn infants with stress ulcers in order to reduce the total load and concentration of gastric hydrochloric acid during massive acute gastric bleeding.1 Antacid therapy may cause aluminum hydroxide "bezoar" in a newborn infant. This report confirms this possibility and suggests a rationale for its occurrence and therapy.
CASE REPORT
This newborn infant was born at 40 weeks' gestation with a birth weight of 3.3 kg, following an uneventful pregnancy and labor. A large left diaphragmatic hernia caused severe anoxia requiring resuscitation in the delivery room.
This article has been cited by other articles:
![]() |
V. M. Tsou, P. R. Bishop, and M. J. Nowicki Colonic Sunflower Seed Bezoar Pediatrics, June 1, 1997; 99(6): 896 - 896. [Full Text] [PDF] |
||||
![]() |
K. S. Strozik, A. H. Walele, and H. Hoffman Bezoar in a Preterm Baby Associated with Sucralfate Clinical Pediatrics, August 1, 1996; 35(8): 423 - 424. [PDF] |
||||
![]() |
H. Kotlus Rosenberg Antacid Bezoar in a Premature Infant Clinical Pediatrics, August 1, 1982; 21(8): 503 - 504. [PDF] |
||||






